Investing.com - Concentrix (NASDAQ: CNXC) reported first quarter EPS of $2.56, $0.24 worse than the analyst estimate of $2.80. Revenue for the quarter came in at $1.64B versus the consensus estimate of $1.64B.
Guidance
Concentrix sees Q2 2023 revenue of $1.64B-$1.67B versus the analyst consensus of $1.64B.
Concentrix sees FY 2023 revenue of $6.71B-$6.83B versus the analyst consensus of $6.79B.
Concentrix's stock price closed at $121.77. It is down -8.55% in the last 3 months and down -30.09% in the last 12 months.
Concentrix saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Concentrix's stock price’s past reactions to earnings here.
According to InvestingPro, Concentrix's Financial Health score is "good performance".
Check out Concentrix's recent earnings performance, and Concentrix's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar